Altered plasma levels of nerve growth factor and transforming growth factor-β2 in type-1 diabetes mellitus

Brain, Behavior, and Immunity

Volumn 13, Issue 4, 1999, Pages 361-366

  Azar, Sami T ^a   Major, Stella C ^a   Safieh Garabedian, Bared ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Autoimmunity; NGF; TGF 2; Type 1 diabetes

Indexed keywords

CYTOKINE; HEMOGLOBIN A1C; IMMUNOSUPPRESSIVE AGENT; INSULIN; NERVE GROWTH FACTOR; ORAL ANTIDIABETIC AGENT; TRANSFORMING GROWTH FACTOR BETA2;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0033406199     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1999.0554     Document Type: Article

References (27)

1. Bonini S., Lambiase A., Bonini S., Angelucci F., Magrini L., Manni L., Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc. Natl. Acad. Sci. USA. 93:1996;10955-10960.
2. Bracci-Laudiero L., Aloe L., Levi-Montalcini R., Butinelli C., Schilter D., Gillessen S., Otten U. Multiple sclerosis patients express increased levels of nerve growth factor in cerebrospinal fluid. Neurosci. Lett. 147:1992;9-12.
3. Bruijn J. A., Roos A., De Geus B., De Heer E. Transforming growth factor β and the glomerular extracellular matrix in renal pathology. J Lab. Clin. Med. 123:1994;34-47.
4. Constam D. B., Philipp J., Malipiero U., Ten Dijke P., Schachner M., Fontana A. Differential expression of transforming growth factor-β 1, β 2 and β 3 by glioblastoma cells, astrocytes and microglia. J. Immunol. 148:1992;1404-1410.
5. Dicou E., Masson C., Jabbour W., Nerriere V. Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients. Neuroreport. 5:1993;321-324.
6. Ehihard P. B., Erb P., Graumann U., Otten U. Expression of nerve growth factor and nerve growth factor tyrosine kinase Trk in activated CD4-positive T cell clones. Proc. Natl. Acad. Sci. USA. 90:1993;10981-10984.
7. Faradji V., Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol. Scand. 81:1990;402-406.
8. Fernyhough P., Diemel L. T., Brewster W. J., Tomlinson D. R. Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment. Neuroscience. 62:1994;337-344.
9. Hellweg R., Hartung H. D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 26:1990;258-267.
10. Letterio J. J., Roberts A. TGF-β: A critical modulator of immune cell function. Clin. Immunol. Immunopathol. 84:1997;244-250.
11. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1989;1154-1162.
12. Mandrup-Poulson T., Helqvist S., Molvig J., Wogenson L., Nerup J. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin dependent diabetes mellitus. Autoimmmunity. 4:1989;191-218.
13. Ordonez O., Fernandez A., Perez R., Sotelo J. Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice. J. Neurol. Sci. 121:1994;163-166.
14. Park I-S., Kiyomoto H., Abboud S. L., Abboud H. E. Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes. 46:1997;473-480.
15. Pfeiffer A., Middleberg-Bisping K., Drewes C., Schatz H. Elevated plasma levels of transforming growth factor-β1 in NIDDM. Diabetes Care. 18:1996;1113-1117.
16. Roberts A. B., Sporn M. B. Peptide growth factors and their receptors. Sporn M. B., Roberts A. B. Handbook of experimental pharmacology. 1990;419-472 Springer-Verlag, Berlin.
17. Rocko M. V., Chen Y., Goldfarb S., Ziyadeh F. N. Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int. 41:1992;107-114.
18. Santambrogio I., Benedetti M., Chao M., Muzaffar R., Kulig K., Gabellini M., Hochwald G. Nerve growth factor production by lymphocytes. J. Immunol. 153:1994;4488-4495.
19. Schattner A. Lymphokines in autoimmunity - A critical review. Clin. Immunol. Immunopathol. 70:1994;177-189.
20. Sharma K., Ziyadeh F. N. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes. 44:1995;1139-1146.
21. 1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
22. Thorpe L. W., Perez-Polo J. R. The influence of nerve growth factor on the vitro proliferative response of rat spleen lymphocyte. J. Neurosci. Res. 18:1989;134-139.
23. Tisch R., Mcdevitt H. Insulin-dependent diabetes mellitus. Cell. 85:1996;291-297.
24. Torcia M., Bracci-Laudiero L., Lucibello M., Nencioni L., Labardi D., Rubartelli A., Cozzolino F., Aloe L., Garaci E. Nerve growth factor is an autocrine survival factor for memory B-lymphocytes. Cell. 85:1996;345-356.
25. Wolf G., Sharma K., Chen Y., Ericksen M., Ziyadeh F. N. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int. 42:1992;647-656.
26. Yamamoto T., Nakamura T., Noble N. A., Ruoslahti E., Border W. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. USA. 90:1993;1814-1818.
27. Ziyadeh F. N., Shamar K., Ericksen M., Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β J. Clin. Invest. 93:1994;536-542.